SmartPeptide
SleepLimited human evidence

DSIP

Delta sleep-inducing peptide originally isolated in studies of EEG slow-wave activity. Modern human data is sparse.

Educational only — not medical advice. SmartPeptide does not prescribe, diagnose, or treat. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.

What the research shows

1970s–1980s studies described EEG slow-wave changes and effects on stress markers. Some small clinical reports in chronic insomnia and pain populations.

What's still experimental

Very little modern, well-controlled human research. Mechanisms remain only partially characterized.

Anecdotal / community reports

Sleep-quality reports vary wildly online; placebo effects are likely substantial.

Anecdotal reports are NOT scientific evidence. They reflect personal experience and may not generalize.

Live research

Updated hourly · sourced from PubMed + ClinicalTrials.gov
PubMed papers
519
total
Human studies
0
MeSH: humans
Clinical trials
0
published
Active trials
13
83 total registered

Clinical trials (ClinicalTrials.gov)

All trials for "delta sleep inducing peptide"

Known risks

Limited modern clinical data.

Reported side effects

Poorly characterized.

What requires medical supervision

Limited modern safety data. Use only with clinician oversight.

Questions for your clinician

  • What modern (post-2010) clinical evidence exists?
  • How does DSIP compare with established sleep interventions?

Editorially curated references

Discussions about DSIP

Start a discussion
No discussions yet — be the first. Share what you've learned, what worked, what didn't, or a study you want translated into plain English.
See all DSIP discussions Native, moderated, no buying or selling